Free Trial
NYSE:CHRO

Chromocell Therapeutics (CHRO) Stock Price, News & Analysis

Chromocell Therapeutics logo
$1.34 +0.08 (+6.35%)
Closing price 07/1/2025
Extended Trading
$1.34 0.00 (0.00%)
As of 07/1/2025 07:49 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Chromocell Therapeutics Stock (NYSE:CHRO)

Key Stats

Today's Range
$1.23
$1.48
50-Day Range
$1.34
$13.50
52-Week Range
$4.50
$38.00
Volume
194,032 shs
Average Volume
47,337 shs
Market Capitalization
$8.69 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CHRO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Chromocell Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

CHRO Stock News Headlines

HIDDEN IN THE BOOK OF GENESIS…
“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 trillion vault of untapped American wealth. Former CIA advisor Jim Rickards calls it the “Old Testament Wealth Code” — and says it could transform your financial future. He’s revealing everything in a new presentation.
Ligand subsidiaries, Chromocell Therapeutics to merge
Chromocell Therapeutics Corp (CHRO)
Channel Therapeutics Corporation (CHRO)
See More Headlines

CHRO Stock Analysis - Frequently Asked Questions

Chromocell Therapeutics' stock was trading at $6.41 at the start of the year. Since then, CHRO stock has decreased by 79.1% and is now trading at $1.34.

Chromocell Therapeutics shares reverse split on the morning of Wednesday, July 2nd 2025.A 1-10 reverse split was announced. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, July 1st 2025. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Chromocell Therapeutics (CHRO) raised $7 million in an initial public offering on Friday, February 16th 2024. The company issued 1,100,000 shares at a price of $6.00 per share.

Shares of CHRO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
7/26/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
Pharmaceutical Products
Current Symbol
NYSE:CHRO
Previous Symbol
NYSE:CHRO
CIK
1919246
Fax
N/A
Employees
4
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($1.24)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$7.38 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
-453.90%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.60
Quick Ratio
0.60

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($1.65) per share
Price / Book
-0.81

Miscellaneous

Outstanding Shares
6,485,000
Free Float
5,039,000
Market Cap
$8.69 million
Optionable
N/A
Beta
3.63
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (NYSE:CHRO) was last updated on 7/26/2025 by MarketBeat.com Staff
From Our Partners